Dine Brands Adopts Poison Pill to Block Applebee's and IHOP Takeover Bid

Dine Brands' board has adopted a stockholder rights plan — a poison pill — that lets shareholders buy stock at a 50% discount if any activist investor accumulates a 10%-or-greater stake, or a passive investor builds a 20%-or-greater position, the company announced Thursday.

The plan expires on Oct. 27, 2027, and covers shareholders who held stock before Nov. 9, 2026. The Glendale, California-based parent of Applebee's and IHOP, both heavily franchised brands, took the step after Bloomberg reported Wednesday that a group of investors including Arkhouse Management and Cobblers Cove Capital was trying to buy the company.

What does the pill change for the would-be buyers?

It raises the cost of creeping control. Bloomberg reported the investor group already has "economic exposure to almost 20% of Dine Brands' shares through swaps and other instruments." Neither Dine nor the suitors confirmed a potential price. Bloomberg pegged it at $39 per share — a premium over the $32.01 close on Oct. 27, the last trading day before acquisition reports drove a spike in both volume and share price, according to company data.

CEO John Peyton framed the move as routine protection rather than defiance. The plan, he said in an emailed statement, "is a standard practice to ensure all stockholders are protected from opportunistic share accumulations that could lead to an effective control position without stockholders receiving an appropriate premium value."

Peyton said the rights plan buys the board time to evaluate options and make an informed decision that maximizes shareholder value. He also defended the operating strategy:

"The Board and management team of Dine are executing against a strategy to unlock our brands' full potential by investing in long-term initiatives – such as our dual brand concept – that are driving results," Peyton said.

The dual-brand initiative combines Applebee's and IHOP in shared buildings, a format Dine has positioned as a key growth lever for its franchise-heavy system.

A broader turn away from public markets

The takeover attempt lands amid a wider wave of restaurant turnarounds. Several brands have chosen, or are weighing, exits from public ownership to escape quarterly market pressure:

• Pizza Hut has gone private as its parent works through a turnaround.
• Wendy's is considering a $1.4 billion bid received earlier this week; the burger chain has not adopted a shareholder rights plan in response.
• Jack in the Box took a poison pill last year to block a takeover attempt from Sardar Biglari, a prominent restaurant activist investor.

The Dine pill runs for nearly three years, a window long enough for the board to weigh alternatives — including a negotiated sale at a full premium — without facing a hostile accumulation at $39 or below.

Whether Arkhouse and Cobblers Cove raise their offer, walk away, or find a route around the plan will shape the next chapter for the company behind roughly two of the country's largest family-dining chains.